Medical update: Scottish Medicines Consortium (SMC)
Scottish Medicines Consortium (SMC): Hydrocortisone granules in capsules for opening (brand name: Alkindi®) for adrenal insufficiency.
SMC has accepted hydrocortisone granules for restricted use for the replacement therapy of adrenal insufficiency. This acceptance is limited to use in infants and young children aged from birth to less than six years old, where the only options to get the right dose are to break up and crush hydrocortisone tablets, produce special solutions or to use hydrocortisone buccal tablets (that dissolve when held between the gum and the cheek) that are not licensed (approved) for treating adrenal insufficiency. There is a press release on Diurnal’s website https://diurnal.co.uk/non-healthcare-professionals/media/news/scottish-medicines-consortium-approves-the-use-of-alkindi-as-first-line-treatment-for-paediatric-adrenal-insufficiency/
If your healthcare professional thinks that hydrocortisone granules for use as described above is the right medicine for your child, they should be able to have the treatment on the NHS in Scotland. For further information see: Medicines in Scotland: What’s the right treatment for me?